Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure It provides physician offices and ...

Insurance companies access a variety of medical and personal records to assess your life expectancy ...

One week Niven Hopkins thought he had a sore foot, and the next, he was facing a life-changing diagnosis.

Abbott (NYSE: ABT), a global healthcare leader, announced today it has secured CE Mark for the world's first dual ...

The world's first dual continuous glucose and ketone monitor is designed to help prevent diabetic ketoacidosis (DKA).

Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.

ABT wins the CE Mark for Libre Duo sensors that track glucose and ketones every minute, aiming to spot DKA risks earlier and reduce routine testing.

ABT wins CE Mark for Libre Duo systems, the first dual glucose-ketone sensors, enabling real-time monitoring as European rollout begins later this year.

Abbott has secured CE Mark for a dual glucose ketone sensing technology for people with diabetes. Branded as Libre Duo and Libre Duo 10 Day, the systems are designed to continuously measure glucose ...

During a recent debate, Los Angeles mayoral candidate Spencer Pratt argued that drug abuse — including "super meth" — has been largely ignored as a factor when attempting to address the city's ...

In the wake of several high-profile electronic monitoring failures — the most recent leading to the killing of a Chicago ...

MiniMed (NASDAQ: MMED), a global leader in diabetes technology, today announced an expanded agreement with Abbott to collaborate on commercializing dual glucose-ketone sensors designed to integrate ...